Global, regional, and national burden of gastrointestinal cancers among adolescents and young adults from 1990 to 2019, and burden prediction to 2040

被引：0
作者：
Peng, Jieyu [1 ,2 ]
Huang, Shu [3 ,4 ]
Wang, Xiaohong [5 ]
Shi, Xiaomin [1 ,2 ]
Xu, Huan [1 ,2 ]
Wang, Ping [1 ,2 ]
Chen, Qi [1 ,2 ]
Zhang, Wei [1 ,2 ]
Shi, Lei [1 ,2 ]
Peng, Yan [1 ,2 ]
Wang, Nanjun [6 ]
Tang, Xiaowei [1 ,2 ]
机构：
[1] Southwest Med Univ, Affiliated Hosp, Dept Gastroenterol, St Taiping 25, Luzhou 646099, Sichuan Provinc, Peoples R China
[2] Nucl Med & Mol Imaging Key Lab Sichuan Prov, Luzhou, Peoples R China
[3] Lianshui Cty People Hosp, Dept Gastroenterol, Huaian, Peoples R China
[4] Nanjing Med Univ, Lianshui People Hosp, Kangda Coll, Dept Gastroenterol, Huaian, Peoples R China
[5] Xuzhou Med Univ, Xuzhou Cent Hosp, Xuzhou Clin Sch, Dept Gastroenterol, Xuzhou, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Gastroenterol & Hepatol, 28 Fuxing Rd, Beijing 100853, Peoples R China
来源：
BMC PUBLIC HEALTH | 2024年 / 24卷 / 01期
关键词：
Gastrointestinal cancers; Global burden of disease; Adolescents and young adults; Prediction; COLORECTAL-CANCER; GASTRIC-CANCER; RISK-FACTORS; MORTALITY; DISEASE; TRENDS; AGE;
D O I：
10.1186/s12889-024-20777-2
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Background Gastrointestinal (GI) cancers have heavily burdened public health. Few studies reported GI cancer burden among adolescents and young adults (AYA). To address this gap, we explored the burden of GI cancer among people aged 15-39. Methods We retrieved data from the Global Burden of Disease Study 2019 Data Resources. The average annual percent change (AAPC) of rates was calculated by linear regression analysis of the natural logarithm. Bayesian age-period-cohort model was applied to predict the future burden. Results In 2019, there were 171,857 (95% uncertain interval [95% UI]: 157,092-187,974) new GI cancer cases with a rate of 5.79/100,000 (95% UI: 5.29-6.33) and 91,033 (95% UI: 83,156-99,399) deaths at a rate of 3.07/100,000 (95% UI: 2.80-3.35) among AYA. The number of prevalent cases and disability-adjusted life years (DALYs) were 722,573 (95% UI: 660,806-789,476) and 5,151,294 (95% UI: 4,706,065-56,188,77), with rates of 24.35/100,000 (95% UI: 22.27-26.60) and 173.57/100,000 (95% UI: 158.57-189.32) respectively. The overall rates of mortality (AAPC = -1.281, p < 0.001) and DALY (AAPC = -1.283, p < 0.001) of GI cancers declined during the past 30 years, while the incidence rate (AAPC = -0.270, p = 0.074) remained stable and the prevalence rate (AAPC = 1.066, p < 0.001) increased. The burden of colorectal cancer (CRC) and pancreatic cancer increased, while those of stomach cancer (SC) and liver cancer (LC) declined. Among the 21 GBD regions, East Asia exhibited the highest burden, while within the five SDI regions, high-middle SDI locations showed the highest rates across all four indicators. CRC, SC, and LC emerged as the primary culprits, attaining a position within the top ten absolute DALYs for all AYA cancers. There were predicted to be 315,792 new cases and 174,068 deaths of GI cancers among AYA in 2040. Conclusions Despite the decrease in mortality and DALY rates of GI cancers among AYA, they remain prevalent. The burden varied with locations, SDI levels, sexes, and cancer types. Sufficient attention and multi-party cooperation are needed to control the widespread public health issue.
引用
收藏
页数：17
相关论文
共 54 条
[1]  
Bray F., Laversanne M., Sung H., Ferlay J., Siegel R.L., Soerjomataram I., Et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 74, pp. 229-263, (2024)
[2]  
Arnold M., Abnet C.C., Neale R.E., Vignat J., Giovannucci E.L., McGlynn K.A., Et al., Global Burden of 5 Major Types of Gastrointestinal Cancer, Gastroenterology, 159, (2020)
[3]  
Smith A.W., Seibel N.L., Lewis D.R., Albritton K.H., Blair D.F., Blanke C.D., Et al., Next steps for adolescent and young adult oncology workshop: An update on progress and recommendations for the future, Cancer, 122, pp. 988-999, (2016)
[4]  
The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet Oncol, 23, 1, pp. 27-52, (2022)
[5]  
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017, Lancet Oncol, 20, 9, pp. 1211-1225, (2019)
[6]  
Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019, Lancet Gastroenterol Hepatol, 7, 7, pp. 627-647, (2022)
[7]  
Liu Y., Zheng J., Hao J., Wang R.R., Liu X., Gu P., Et al., Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019, Cancer Med, 11, pp. 1310-1323, (2022)
[8]  
Wang Y., Huang X., Cheryala M., Aloysius M., Zheng B., Yang K., Et al., Global increase of colorectal cancer in young adults over the last 30 years: an analysis of the Global Burden of Disease Study 2019, J Gastroenterol Hepatol, 38, pp. 1552-1558, (2023)
[9]  
Zhang Z., Wang J., Song N., Shi L., Du J., The global, regional, and national burden of stomach cancer among adolescents and young adults in 204 countries and territories, 1990–2019: A population-based study, Front Public Health, 11, (2023)
[10]  
Codipilly D.C., Sawas T., Dhaliwal L., Johnson M.L., Lansing R., Wang K.K., Et al., Epidemiology and Outcomes of Young-Onset Esophageal Adenocarcinoma: An Analysis from a Population-Based Database, Cancer Epidemiol Biomarkers Prev, 30, pp. 142-149, (2021)
123456